Imaging in the Era of COVID-19 - maintaining safety above all
Date: 7 May 2020
Time: 9am PST | 5pm BST
COVID-19 has caused increased pressure on the medical community to unprecedented levels. Whilst patients and providers navigate these uncertain times, many questions are arising about how to continue to serve their practice and patients safely. This webinar aims to provide information to support safe engagement with imaging for patients, providers, and researchers. Insights in this webinar come from the perspective of public health expert, and Principal Investigator in the first study on COVID-19 recovery, Dr. Banerjee.
- How the COVID-19 global pandemic is impacting medical research
- The importance of non-contact imaging for patient safety
- The impact of covid-19 on societal well-being and healthcare
Rajarshi Banerjee, BMBCh MA MRCP MPH DPhil
Founder, Chief Executive Officer & Board Member of Perspectum
Rajarshi Banerjee is the CEO of Perspectum, which he co-founded in 2012. The company currently employs over 178 people in Oxford, Singapore, Dallas, and San Francisco. He graduated in medicine from the University of Oxford and went on to complete a Masters in Public Health at the London School of Hygiene and Tropical Medicine, before returning to Oxford, for his doctorate. He developed the magnetic resonance imaging techniques for rapid non-invasive liver assessment in Oxford and commercialised the method as LiverMultiScan, which is now FDA cleared and used in over 200 sites. He has many years of experience in running clinical trials and working in multidisciplinary scientific teams to develop applications for cutting-edge imaging technology and is a keen advocate of smart trial design.
Dr Banerjee continues to work as a Consultant Physician with Oxford University Hospitals NHS Foundation Trust, with research into the phenotyping of liver disease at an individual and population level in adults and children.